These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 37269646)
1. Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains. Mikkelsen JD; Kaad S; Aripaka SS; Finsen B Neurobiol Aging; 2023 Sep; 129():50-57. PubMed ID: 37269646 [TBL] [Abstract][Full Text] [Related]
2. Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J. Kumar A; Scarpa M; Nordberg A Alzheimers Dement; 2024 Apr; 20(4):2589-2605. PubMed ID: 38363009 [TBL] [Abstract][Full Text] [Related]
3. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging. Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145 [TBL] [Abstract][Full Text] [Related]
4. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem. Bertoglio D; Verhaeghe J; Wyffels L; Miranda A; Stroobants S; Mrzljak L; Dominguez C; Skinbjerg M; Bard J; Liu L; Munoz-Sanjuan I; Staelens S J Nucl Med; 2022 Jun; 63(6):942-947. PubMed ID: 34531262 [TBL] [Abstract][Full Text] [Related]
5. In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET. Mecca AP; Chen MK; O'Dell RS; Naganawa M; Toyonaga T; Godek TA; Harris JE; Bartlett HH; Zhao W; Nabulsi NB; Wyk BCV; Varma P; Arnsten AFT; Huang Y; Carson RE; van Dyck CH Alzheimers Dement; 2020 Jul; 16(7):974-982. PubMed ID: 32400950 [TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of synaptic density with [ Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391 [TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Thomsen MB; Jacobsen J; Lillethorup TP; Schacht AC; Simonsen M; Romero-Ramos M; Brooks DJ; Landau AM J Cereb Blood Flow Metab; 2021 Apr; 41(4):819-830. PubMed ID: 32538280 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates. Li S; Cai Z; Wu X; Holden D; Pracitto R; Kapinos M; Gao H; Labaree D; Nabulsi N; Carson RE; Huang Y ACS Chem Neurosci; 2019 Mar; 10(3):1544-1554. PubMed ID: 30396272 [TBL] [Abstract][Full Text] [Related]
10. Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE). Pazarlar BA; Aripaka SS; Petukhov V; Pinborg L; Khodosevich K; Mikkelsen JD Mol Brain; 2022 May; 15(1):45. PubMed ID: 35578248 [TBL] [Abstract][Full Text] [Related]
11. Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain. Varnäs K; Stepanov V; Halldin C Synapse; 2020 Oct; 74(10):e22157. PubMed ID: 32259300 [TBL] [Abstract][Full Text] [Related]
12. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity. Patel S; Knight A; Krause S; Teceno T; Tresse C; Li S; Cai Z; Gouasmat A; Carroll VM; Barret O; Gottmukkala V; Zhang W; Xiang X; Morley T; Huang Y; Passchier J Mol Imaging Biol; 2020 Aug; 22(4):832-841. PubMed ID: 31728839 [TBL] [Abstract][Full Text] [Related]
13. Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET. Silva-Rudberg JA; Salardini E; O'Dell RS; Chen MK; Ra J; Georgelos JK; Morehouse MR; Melino KP; Varma P; Toyonaga T; Nabulsi NB; Huang Y; Carson RE; van Dyck CH; Mecca AP Am J Geriatr Psychiatry; 2024 Jan; 32(1):17-28. PubMed ID: 37673749 [TBL] [Abstract][Full Text] [Related]
14. Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer's Disease Patients. Metaxas A; Thygesen C; Briting SRR; Landau AM; Darvesh S; Finsen B Front Cell Neurosci; 2019; 13():538. PubMed ID: 31866830 [TBL] [Abstract][Full Text] [Related]
15. A single dose of cocaine raises SV2A density in hippocampus of adolescent rats. Rossi R; Bærentzen SL; Thomsen MB; Real CC; Wegener G; Grassi-Oliveira R; Gjedde A; Landau AM Acta Neuropsychiatr; 2024 Apr; 36(2):109-117. PubMed ID: 36847240 [TBL] [Abstract][Full Text] [Related]
16. Imaging of Synaptic Density in Neurodegenerative Disorders. Carson RE; Naganawa M; Toyonaga T; Koohsari S; Yang Y; Chen MK; Matuskey D; Finnema SJ J Nucl Med; 2022 Jun; 63(Suppl 1):60S-67S. PubMed ID: 35649655 [TBL] [Abstract][Full Text] [Related]